Indian multinational pharmaceutical company, Zydus Lifesciences Limited, has received final approval from the United States ...

Zydus Lifesciences receives USFDA approval to manufacture generic Niacin extended-release tablets for lowering cholesterol.

Ahmedabad: Zydus Lifesciences Limited has announced that the company has received final approval from the United States Food ...

Zydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator to manufacture the ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

In a recent study, one-year MACE incidences were 1.79, 2.58, and 4.03 per 100 patient-years for early, late, and no ezetimibe added to statins.

Inflammation is likely a key player in atherosclerosis and related cardiovascular events, but questions remain about its role ...

Cardiologists have known for more than three decades that statin-type cholesterol-lowering drugs can lower levels of ubiquinone. Most people know ubiquinone by the name coenzyme Q10 or CoQ10.

An editorial in Brain Medicine calls for urgent action to address the often-overlooked toxicity of commonly prescribed drugs.

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Treating high cholesterol quickly and aggressively after a heart attack may help prevent thousands of new heart attacks and ...

With efforts being ramped up to slash heart attack and stroke risks, many doctors argue that taking statins over the age of ...